A study reported by UK outlets suggests that people who complete treatment with injectable weight-loss jabs may be able to maintain their weight-loss results by switching to a daily oral pill afterward. The reports say the research examined whether continuing treatment in pill form could reduce the likelihood of regaining weight after the injectable course ends. Sky News and the Daily Mail both describe the approach as a maintenance strategy that could support longer-term weight control. The Daily Mail adds that the idea could potentially benefit a large number of patients and reduce the need for ongoing injections, though the coverage focuses primarily on the reported findings of the trial rather than details such as duration, size, or specific outcomes. Overall, the articles present the switch as a potential way to help patients keep pounds off after finishing jab-based therapy, but they do so as “study suggests,” reflecting that the evidence is drawn from a particular trial rather than routine clinical practice.